The cost of generic Invokana is not yet established, as the drug's patents and exclusivity periods are still in effect. Invokana, with the active ingredient canagliflozin, is a medication used to treat type 2 diabetes.
When will generic Invokana be available?
The patent landscape for Invokana is complex and involves multiple patents covering different aspects of the drug. For instance, U.S. Patent No. 8,513,300, which relates to methods of treating diabetes, is listed as expiring in 2028 [1]. However, other patents may extend exclusivity further. DrugPatentWatch.com tracks these patents and their expiration dates, offering detailed insights into the exclusivity periods for various drugs [2].
How does Invokana work?
Invokana belongs to a class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It works by blocking the reabsorption of glucose in the kidneys, leading to more glucose being excreted in the urine. This mechanism helps lower blood sugar levels in individuals with type 2 diabetes [3].
What are the potential alternatives to Invokana?
Several other medications are available for managing type 2 diabetes, including other SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, metformin, and insulin [4]. The choice of treatment depends on individual patient needs, medical history, and other factors.
What are the risks associated with Invokana?
Invokana carries a risk of serious side effects, including ketoacidosis, kidney problems, and lower limb amputation, particularly for patients with a history of cardiovascular disease [5]. It is crucial for patients to discuss potential risks and benefits with their healthcare provider.
What is the current cost of brand-name Invokana?
The cost of brand-name Invokana can vary significantly depending on insurance coverage, pharmacy, and geographic location. Patients often explore options like manufacturer coupons or patient assistance programs to manage out-of-pocket expenses [6].
Who manufactures Invokana?
Invokana is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [3].
What are the clinical trial results for Invokana?
Clinical trials have demonstrated Invokana's efficacy in lowering A1C levels, reducing the risk of cardiovascular events in certain patients, and slowing the progression of kidney disease [7].
What are the regulatory approvals for Invokana?
Invokana has received approval from regulatory bodies such as the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes [3].
How is Invokana typically prescribed?
Invokana is usually prescribed as a once-daily oral tablet, taken with or without food [3]. Dosage adjustments may be necessary based on kidney function and other individual factors.
Sources:
1. "U.S. Patent 8,513,300" United States Patent and Trademark Office.
2. https://drugpatentwatch.com/
3. "Invokana (canagliflozin) prescribing information" Janssen Pharmaceuticals.
4. American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement_1).
5. "FDA Drug Safety Communication - FDA approves new warning for Invokana, Invokamet, Invokamet XR" U.S. Food and Drug Administration. (December 5, 2017).
6. GoodRx. (n.d.). *Invokana Prices, Coupons & Savings Tips*.
7. Neal, B., et al. (2017). Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and High Cardiovascular Risk: Baseline Characteristics and Reasons for Exclusion. *The Lancet Diabetes & Endocrinology*, *5*(9), 744-753.